Research into areas like cancer could become collateral damage of a broader anti-mRNA push, according to a new study.

Political interference is driving biotech investment overseas, and U.S. patients and workers will pay the price.

Add Yahoo as a preferred source to see more of our stories on Google. Health and Human Services Secretary Robert F. Kennedy Jr. canceled $500 million of funding for research on mRNA vaccine technology ...

Misinformation about mRNA cancer vaccines threatens their transformative potential in treatment and prevention, highlighting ...

Learn how pharma company Pfizer makes money through prescription drugs, vaccines, oncology treatments, and global ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of uncertainty, scientists worry that revolutionary treatments for cancer, immune ...

EDITOR’S NOTE: The views expressed in this commentary are solely those of the writer. CNN is showcasing the work of The Conversation, a collaboration between journalists and academics to provide news ...

The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine. "We feel that a cure for cancer or to changing cancer patients' ...

Broader biotech positioning aligns with movements tracked across the nasdaq ecosystem.